Lomiko’s Investment, Graphene 3D Lab, Adds 8000 Customers and in Excess Of $1 Million in Revenue Through Graphene Labs Acquisition

Press Releases |

VANCOUVER, BC / August 20, 2015 / LOMIKO METALS INC. ($LMR:CA) ($LMRMF) (FSE: DH8B) (the "Company") is encouraged by the acquisition of Graphene Labs which has graphene patents and production assets which will provide additional revenue to Graphene 3D Lab. Lomiko owns 4,3960,970 shares of Graphene 3D Lab.

"New developments in graphene are increasing at a tremendous rate. Investors should be cautious in claims regarding new companies involved in graphene. Having a strategic partnership with and being a significant shareholder in Graphene 3D Lab, allows Lomiko a unique insight into this new industry", stated A. Paul Gill, CEO.

Graphene Laboratories, a leader in manufacturing and retailing of graphene and advanced materials, owns the Graphene Supermarket website, a leading supplier of such products to customers around the globe. Graphene Laboratories' client list is composed of more than 8,000 customers worldwide, including nearly every Fortune 500 tech company and major research university. Some notable clients are NASA, Ford Motor Co., GE, Apple, Xerox, Samsung, Harvard University, IBM and Stanford University.

Graphene Laboratories also holds a provisional patent relating to the manufacture and processing of graphene. Graphene Laboratories has begun planning on a two-phased development program to advance this manufacturing process from bench-top prototype to a large-scale manufacturing operation.

In addition to the retail offering of graphene products, GLI offers analytical services, prototype development and consulting. The addition of GLI's business and graphene product lines will complement and expand the company's existing business of research, development and production of polymer nanocomposite graphene-based filaments for fused filament fabrication in 3-D printers. Graphene Laboratories will operate as a wholly owned subsidiary of Graphene 3D Lab.

For more information, review the website at www.lomiko.com, contact A. Paul Gill at 604-729-5312 or email: info@lomiko.com.

On Behalf of the Board

"A. Paul Gill"
Chief Executive Officer

We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…